You are here
GSK says 'tailwinds' will lift its consumer healthcare business
CHEAPER generic drugs, which are growing in double-digits, are invading the wellness segment of the global consumer healthcare business in a big way, giving giant drugmakers such as GlaxoSmithKline (GSK) a run for their money.
In Australia, GSK's household-name drug
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org